Alpine Immune Sciences Inc (DELISTED) (ALPN:DL)
64.97
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
Alpine Immune Sciences Cash from Investing (Quarterly): -2.562M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -2.562M |
December 31, 2023 | -112.70M |
September 30, 2023 | -0.535M |
June 30, 2023 | 29.33M |
March 31, 2023 | 28.35M |
December 31, 2022 | -107.90M |
September 30, 2022 | 25.79M |
June 30, 2022 | 6.564M |
March 31, 2022 | -37.80M |
December 31, 2021 | -4.285M |
September 30, 2021 | -62.52M |
June 30, 2021 | 20.87M |
March 31, 2021 | -6.546M |
December 31, 2020 | -96.85M |
September 30, 2020 | 1.843M |
June 30, 2020 | 9.057M |
March 31, 2020 | 13.13M |
December 31, 2019 | 4.388M |
September 30, 2019 | 10.86M |
June 30, 2019 | -17.59M |
March 31, 2019 | 19.10M |
Date | Value |
---|---|
December 31, 2018 | 9.136M |
September 30, 2018 | 15.77M |
June 30, 2018 | 3.338M |
March 31, 2018 | 3.87M |
December 31, 2017 | 1.855M |
September 30, 2017 | -46.63M |
June 30, 2017 | 17.81M |
March 31, 2017 | -2.838M |
December 31, 2016 | 13.15M |
September 30, 2016 | 8.265M |
June 30, 2016 | 5.841M |
March 31, 2016 | -1.95M |
December 31, 2015 | -27.22M |
September 30, 2015 | -35.14M |
June 30, 2015 | -0.035M |
March 31, 2015 | -0.052M |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | -0.0029M |
March 31, 2014 | -0.0011M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-112.70M
Minimum
Dec 2023
29.33M
Maximum
Jun 2023
-14.96M
Average
0.654M
Median
Cash from Investing (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | -2.136B |
Eliem Therapeutics Inc | 13.75M |
Regeneron Pharmaceuticals Inc | -1.687B |
Vera Therapeutics Inc | -219.29M |
Eyenovia Inc | -0.1141M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -27.69M |
Cash from Financing (Quarterly) | 19.35M |
Free Cash Flow | -80.96M |
Free Cash Flow Per Share (Quarterly) | -0.4327 |
Free Cash Flow to Equity (Quarterly) | -27.71M |
Free Cash Flow Yield | -2.30% |